您的位置: 首页 > 农业专利 > 详情页

IMMUNOTHÉRAPIE À BASE DE VECTEURS D'ADMINISTRATION PERSONNALISÉS, ET LEURS UTILISATIONS
专利权人:
Inc.;Advaxis
发明人:
PETIT, Robert,PERRY, Kyle,PRINCIOTTA, Michael F.,O'CONNOR, Daniel J.,OCONNOR, Daniel J.
申请号:
EP16800704
公开号:
EP3302574A4
申请日:
2016.05.26
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
This invention provides a system of providing and creating personalized immunotherapeutic compositions for a subject having a disease or condition, including therapeutic immunotherapy delivery vectors and methods of making the same comprising gene expression constructs expressing peptides associated with one or more neo-epitopes or peptides containing mutations that are specific to a subject's cancer or unhealthy tissue. A delivery vector of this invention includes bacterial vectors including Listeria bacterial vectors; or viral vectors, peptide immunotherapy vectors; or DNA immunotherapy vectors, comprising one or more fusion proteins comprising one or more peptides comprising one or more neo-epitopes present in disease-bearing biological samples obtained from the subject. This invention also provides methods of using the same for inducing an immune response against a disease or condition, including a tumor or cancer, or an infection, or an autoimmune disease or an organ transplant rejection in the subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充